Postchemotherapy and tumor-selective targeting with the La-specific DAB4 monoclonal antibody relates to apoptotic cell clearance
Data(s) |
01/05/2014
|
---|---|
Resumo |
Early identification of tumor responses to treatment is crucial for devising more effective and safer cancer treatments. No widely applicable, noninvasive method currently exists for specifically detecting tumor cell death after cytotoxic treatment and thus for predicting treatment outcomes. |
Identificador | |
Idioma(s) |
eng |
Publicador |
Society of Nuclear Medicine |
Relação |
http://dro.deakin.edu.au/eserv/DU:30071642/denoyer-postchemotherapyand-2014.pdf http://www.dx.doi.org/10.2967/jnumed.113.130559 http://www.ncbi.nlm.nih.gov/pubmed/24676755 |
Direitos |
2014, Society of Nuclear Medicine |
Palavras-Chave | #APOMAB #DAB4 #La #apoptosis #chemotherapy #therapy response #Animals #Antibodies, Monoclonal, Murine-Derived #Antineoplastic Agents #Autoantigens #Binding, Competitive #Cell Proliferation #DNA Breaks, Double-Stranded #Female #Flow Cytometry #Humans #Jurkat Cells #Lymphoma #Male #Mice #Mice, Inbred BALB C #Mice, Inbred C57BL #Neoplasm Transplantation #Prostatic Neoplasms #Protein Binding #Radionuclide Imaging #Ribonucleoproteins #Thymocytes #Thymus Neoplasms #Treatment Outcome |
Tipo |
Journal Article |